Influence of silybin on biophysical properties of phospholipid bilayers

被引:55
作者
Wesolowska, Olga
Lania-Pietrzak, Barbara
Kuzdzal, Micha
Stanczak, Kamila
Mosiadz, Daniela
Dobryszycki, Piotr
Ozyhar, Andrzej
Komorowska, Malgorzata
Hendrich, Andrzej B.
Michalak, Krystyna
机构
[1] Wroclaw Med Univ, Dept Biophys, PL-50368 Wroclaw, Poland
[2] Wroclaw Tech Univ, Div Biochem, Inst Organ Chem Biochem & Biotechnol, PL-50370 Wroclaw, Poland
[3] Wroclaw Tech Univ, Inst Phys, PL-50370 Wroclaw, Poland
关键词
silybin (silibinin); phospholipid bilayer; fluorescence spectroscopy; microcalorimetry; electron spin resonance; flavonoids;
D O I
10.1111/j.1745-7254.2007.00487.x
中图分类号
O6 [化学];
学科分类号
0703 [化学];
摘要
Aim: Silybin (silibinin) is major biologically active flavonolignan extracted from milk thistle (Sylibum marianum). Its biological activities include hepato-protection, anticancer properties, and antioxidant- and membrane-stabilizing functions. Although membranes are postulated to be one of the cellular targets for silybin, little is known about its interaction with phospholipid bilayers. Methods: In the present work, the interactions of silybin with phosphatidylcholine bilayers were studied in detail using fluorescence spectroscopy, microcalorimetry and electron spin resonance techniques. Results: The results showed that silybin interacted with the surface of lipid bilayers. It affected the generalized polarization of the fluorescent probe Prodan, while not influencing the more deeply located Laurdan. Silybin lowered the main phospholipid phase transition temperature as judged by microcalorimetry, and caused the immobilization of spin probe Tempo-palmitate located on the surface of membranes. The mobility of spin probes 5- and 16-doxyl stearic acid was not affected by silybin. Silybin-induced quenching of 1,6-diphe-nyl-1,3,5-hexatriene fluorescence indicated that some flavonoid molecules partitioned into the hydrophobic region of membranes, which did not change significantly the biophysical properties of the deeper membrane regions. Conclusion: Such a behavior of silybin in membranes is in accordance with its postulated biological functions and neglectable side effects of therapies using silybin.
引用
收藏
页码:296 / 306
页数:11
相关论文
共 38 条
[1]
Modulation of liposomal membrane fluidity by flavonoids and isoflavonoids [J].
Arora, A ;
Byrem, TM ;
Nair, MG ;
Strasburg, GM .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2000, 373 (01) :102-109
[2]
PHARMACOKINETIC STUDIES ON IDB-1016, A SILYBIN-PHOSPHATIDYLCHOLINE COMPLEX, IN HEALTHY-HUMAN SUBJECTS [J].
BARZAGHI, N ;
CREMA, F ;
GATTI, G ;
PIFFERI, G ;
PERUCCA, E .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1990, 15 (04) :333-338
[3]
LIPID-PEROXIDATION AND IRREVERSIBLE DAMAGE IN THE RAT HEPATOCYTE MODEL - PROTECTION BY THE SILYBIN PHOSPHOLIPID COMPLEX IDB-1016 [J].
CARINI, R ;
COMOGLIO, A ;
ALBANO, E ;
POLI, G .
BIOCHEMICAL PHARMACOLOGY, 1992, 43 (10) :2111-2115
[4]
SCAVENGING EFFECT OF SILIPIDE, A NEW SILYBIN-PHOSPHOLIPID COMPLEX, ON ETHANOL-DERIVED FREE-RADICALS [J].
COMOGLIO, A ;
TOMASI, A ;
MALANDRINO, S ;
POLI, G ;
ALBANO, E .
BIOCHEMICAL PHARMACOLOGY, 1995, 50 (08) :1313-1316
[5]
Interaction of the breast cancer resistance protein with plant polyphenols [J].
Cooray, HC ;
Janvilisri, T ;
van Veen, HW ;
Hladky, SB ;
Barrand, MA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 317 (01) :269-275
[6]
Silymarin as a new hepatoprotective agent in experimental cholestasis: New possibilities for an ancient medication [J].
Crocenzi, FA ;
Roma, MG .
CURRENT MEDICINAL CHEMISTRY, 2006, 13 (09) :1055-1074
[7]
In vitro antimalarial activity of flavonoid derivatives dehydrosilybin and 8-(1;1)-DMA-kaempferide [J].
de Monbrison, F ;
Maitrejean, M ;
Latour, C ;
Bugnazet, F ;
Peyron, F ;
Barron, D ;
Picot, S .
ACTA TROPICA, 2006, 97 (01) :102-107
[8]
The interaction of flavonoids with membranes: Potential determinant of flavonoid antioxidant effects [J].
Erlejman, AG ;
Verstraeten, SV ;
Fraga, CG ;
Oteiza, PI .
FREE RADICAL RESEARCH, 2004, 38 (12) :1311-1320
[9]
Antitumour activity of the silybin-phosphatidylcholine complex, 1dB 1016, against human ovarian cancer [J].
Gallo, D ;
Giacomelli, S ;
Ferlini, C ;
Raspaglio, G ;
Apollonio, P ;
Prislei, S ;
Riva, A ;
Morazzoni, P ;
Bombardelli, E ;
Scambia, G .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (16) :2403-2410
[10]
Giese L A, 2001, Gastroenterol Nurs, V24, P95, DOI 10.1097/00001610-200103000-00011